Tag: Stephen Van Deventer

April 9, 2020

Asterion Appoints Amy Stephenson as Chief Investment Officer

Asterion Cannabis announces the appointment of Amy Stephenson, MBA, CFA, CPA, CMA, as Chief Investment Officer.
March 31, 2020

Asterion Signs DAA for $400 Million

Asterion Signs Exclusive Definitive Association Agreement for $400 Million Financing, Development and Construction
March 9, 2020

Asterion Cannabis to Participate in the 32nd Annual ROTH Conference

Asterion Cannabis Inc. is pleased to announce that it will participate in the 32nd Annual ROTH Conference taking place in Orange County,...
February 4, 2020

Asterion Cannabis Officially Listed on the Australian Department of Health and Office of Drug Control

Asterion Cannabis is listed as a medicinal cannabis manufacturer and supplier on the Australian government's Department of Health and Office of...
January 27, 2020

Asterion Cannabis Announces Election of New Director

Asterion is pleased to announce the voting results from the Company's 2020 annual general meeting of shareholders held on Friday,...
November 13, 2018

PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H), (the "Company" or "PreveCeutical") announces that it has entered into a non-binding letter of intent dated November 9,...
October 31, 2018

PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), provides an update on its recent due diligence trip (the "Due...